Medtronic PE Ratio 2006-2018 | MDT

Current and historical PE ratio for Medtronic (MDT) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Medtronic (MDT) as of April 30, 2018 is 18.41.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $113.519B 23.81
Stryker (SYK) United States $64.929B 25.97
Boston Scientific (BSX) United States $46.555B 25.95
Baxter (BAX) United States $40.001B 28.62
Zimmer Biomet Holdings (ZBH) United States $22.844B 14.39
ResMed (RMD) United States $15.490B 32.39
Smith & Nephew SNATS (SNN) United Kingdom $15.465B 0.00
Perrigo (PRGO) Ireland $10.581B 14.84
Bio-Rad Laboratories (BIO) United States $9.046B 72.96
Hill-Rom Holdings (HRC) United States $6.207B 22.30
ICU Medical (ICUI) United States $6.175B 57.46
Canopy Growth (CGC) Canada $5.749B 0.00
Agios Pharmaceuticals (AGIO) United States $5.297B 0.00
Insulet (PODD) United States $5.208B 0.00
Haemonetics (HAE) United States $5.062B 52.13
Hutchison China MediTech (HCM) China $4.438B 0.00
Neogen (NEOG) United States $4.224B 67.54
GW Pharmaceuticals (GWPH) United Kingdom $4.134B 0.00
National Vision Holdings (EYE) United States $3.060B 0.00
NuVasive (NUVA) United States $2.724B 27.53
Quidel (QDEL) United States $2.634B 115.26
Phibro Animal Health (PAHC) United States $1.934B 28.71
Abaxis,Inc (ABAX) United States $1.905B 64.07
NxStage Medical (NXTM) United States $1.857B 0.00
VAREX IMAGING (VREX) United States $1.424B 21.94
Eagle Pharmaceuticals (EGRX) United States $1.224B 34.22
Cardiovascular Systems (CSII) United States $1.172B 0.00
Orthofix (OFIX) $1.095B 33.36
Owens & Minor (OMI) United States $1.066B 10.71
OraSure Technologies (OSUR) United States $1.019B 61.81
AtriCure (ATRC) United States $1.017B 0.00
Omeros (OMER) United States $0.968B 0.00
Cerus (CERS) United States $0.960B 0.00
MacroGenics (MGNX) United States $0.920B 0.00
TG Therapeutics (TGTX) United States $0.893B 0.00
Surmodics (SRDX) United States $0.786B 134.66
LeMaitre Vascular (LMAT) United States $0.710B 41.78
Meridian Bioscience (VIVO) United States $0.661B 23.28
PetIQ (PETQ) United States $0.634B 0.00
Insys Therapeutics (INSY) United States $0.602B 0.00
Lantheus Holdings (LNTH) United States $0.528B 13.80
Evolus (EOLS) United States $0.504B 0.00
Surface Oncology (SURF) United States $0.407B 0.00
Utah Medical Products (UTMD) United States $0.364B 24.09
Cytosorbents (CTSO) United States $0.356B 0.00
Quanterix (QTRX) United States $0.324B 0.00
NanoString Technologies (NSTG) United States $0.316B 0.00
BioLife Solutions (BLFS) United States $0.285B 0.00
Rockwell Medical (RMTI) United States $0.225B 0.00
Chimerix (CMRX) United States $0.220B 0.00
Fonar (FONR) United States $0.171B 10.36
Bovie Medical (BVX) United States $0.168B 0.00
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.131B 0.00
Female Health (VERU) United States $0.113B 0.00
Trinity Biotech (TRIB) Ireland $0.105B 31.25
Oramed Pharmaceuticals (ORMP) Israel $0.098B 0.00
United-Guardian (UG) United States $0.089B 20.91
Neurotrope (NTRP) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.075B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.049B 0.00
Capricor Therapeutics (CAPR) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Myomo (MYO) United States $0.030B 0.00
Senestech (SNES) United States $0.025B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00